UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:NFATC2-ATP9A |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: NFATC2-ATP9A | FusionPDB ID: 58787 | FusionGDB2.0 ID: 58787 | Hgene | Tgene | Gene symbol | NFATC2 | ATP9A | Gene ID | 4773 | 10079 |
Gene name | nuclear factor of activated T cells 2 | ATPase phospholipid transporting 9A (putative) | |
Synonyms | NFAT1|NFATP | ATPIIA | |
Cytomap | 20q13.2 | 20q13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | nuclear factor of activated T-cells, cytoplasmic 2NF-ATc2NFAT pre-existing subunitNFAT transcription complex, preexisting componentT cell transcription factor NFAT1nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2nuclear fact | probable phospholipid-transporting ATPase IIAATPase type IV, phospholipid-transporting (P-type),(putative)ATPase, class II, type 9Aphospholipid-transporting ATPase IIA | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | Q8NCF5 | O75110 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000371564, ENST00000396009, ENST00000414705, ENST00000609507, ENST00000609943, ENST00000610033, | ENST00000477492, ENST00000311637, ENST00000338821, ENST00000402822, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 9 X 9 X 5=405 | 18 X 17 X 7=2142 |
# samples | 8 | 18 | |
** MAII score | log2(8/405*10)=-2.33985000288462 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(18/2142*10)=-3.57288966842058 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: NFATC2 [Title/Abstract] AND ATP9A [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ATP9A(50344281)-NFATC2(50078782), # samples:1 NFATC2(50071085)-ATP9A(50292747), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | NFATC2-ATP9A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. NFATC2-ATP9A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. NFATC2-ATP9A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. NFATC2-ATP9A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. NFATC2-ATP9A seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. NFATC2-ATP9A seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. NFATC2-ATP9A seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF. NFATC2-ATP9A seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. NFATC2-ATP9A seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. NFATC2-ATP9A seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | NFATC2 | GO:0016477 | cell migration | 21871017 |
Hgene | NFATC2 | GO:0045893 | positive regulation of transcription, DNA-templated | 15790681 |
Hgene | NFATC2 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation | 23853098 |
Fusion gene breakpoints across NFATC2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ATP9A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-A4PD-01A | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000371564 | NFATC2 | chr20 | 50071085 | - | ENST00000311637 | ATP9A | chr20 | 50292747 | - | 9111 | 2069 | 211 | 4413 | 1400 |
ENST00000371564 | NFATC2 | chr20 | 50071085 | - | ENST00000338821 | ATP9A | chr20 | 50292747 | - | 9111 | 2069 | 211 | 4413 | 1400 |
ENST00000371564 | NFATC2 | chr20 | 50071085 | - | ENST00000402822 | ATP9A | chr20 | 50292747 | - | 4762 | 2069 | 211 | 4413 | 1400 |
ENST00000396009 | NFATC2 | chr20 | 50071085 | - | ENST00000311637 | ATP9A | chr20 | 50292747 | - | 9111 | 2069 | 211 | 4413 | 1400 |
ENST00000396009 | NFATC2 | chr20 | 50071085 | - | ENST00000338821 | ATP9A | chr20 | 50292747 | - | 9111 | 2069 | 211 | 4413 | 1400 |
ENST00000396009 | NFATC2 | chr20 | 50071085 | - | ENST00000402822 | ATP9A | chr20 | 50292747 | - | 4762 | 2069 | 211 | 4413 | 1400 |
ENST00000609943 | NFATC2 | chr20 | 50071085 | - | ENST00000311637 | ATP9A | chr20 | 50292747 | - | 9033 | 1991 | 202 | 4335 | 1377 |
ENST00000609943 | NFATC2 | chr20 | 50071085 | - | ENST00000338821 | ATP9A | chr20 | 50292747 | - | 9033 | 1991 | 202 | 4335 | 1377 |
ENST00000609943 | NFATC2 | chr20 | 50071085 | - | ENST00000402822 | ATP9A | chr20 | 50292747 | - | 4684 | 1991 | 202 | 4335 | 1377 |
ENST00000414705 | NFATC2 | chr20 | 50071085 | - | ENST00000311637 | ATP9A | chr20 | 50292747 | - | 8831 | 1789 | 0 | 4133 | 1377 |
ENST00000414705 | NFATC2 | chr20 | 50071085 | - | ENST00000338821 | ATP9A | chr20 | 50292747 | - | 8831 | 1789 | 0 | 4133 | 1377 |
ENST00000414705 | NFATC2 | chr20 | 50071085 | - | ENST00000402822 | ATP9A | chr20 | 50292747 | - | 4482 | 1789 | 0 | 4133 | 1377 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000371564 | ENST00000311637 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.00045492 | 0.99954504 |
ENST00000371564 | ENST00000338821 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.00045492 | 0.99954504 |
ENST00000371564 | ENST00000402822 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.003135994 | 0.9968641 |
ENST00000396009 | ENST00000311637 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.00045492 | 0.99954504 |
ENST00000396009 | ENST00000338821 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.00045492 | 0.99954504 |
ENST00000396009 | ENST00000402822 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.003135994 | 0.9968641 |
ENST00000609943 | ENST00000311637 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.000456358 | 0.9995436 |
ENST00000609943 | ENST00000338821 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.000456358 | 0.9995436 |
ENST00000609943 | ENST00000402822 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.003069726 | 0.9969303 |
ENST00000414705 | ENST00000311637 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.000345421 | 0.99965453 |
ENST00000414705 | ENST00000338821 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.000345421 | 0.99965453 |
ENST00000414705 | ENST00000402822 | NFATC2 | chr20 | 50071085 | - | ATP9A | chr20 | 50292747 | - | 0.002424876 | 0.9975751 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >58787_58787_1_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000371564_ATP9A_chr20_50292747_ENST00000311637_length(amino acids)=1400AA_BP=619 MRAMNAPERQPQPDGGDAPGHEPGGSPQDELDFSILFDYEYLNPNEEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFG EPDRVGPQKFLSAAKPAGASGLSPRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSAS FISDTFSPYTSPCVSPNNGGPDDLCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGA SPQRSRSPSPQPSSHVAPQDHGSPAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQ GERRNSAPESILLVPPTWPKPLVPAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHG YMENKPLGLQIFIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGR KNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTG RELRSVMNTSNPRSKIGLFDLEVNCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSK IPGTVVRSSTIPEQLGRISYLLTDKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVH EAVKAIALCHNVTPVYESNGVTDQAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYE SKRMGIIVRDESTGEITFYMKGADVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIE SLEMEMELLCLTGVEDQLQADVRPTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCAL VISGDSLEVCLKYYEYEFMELACQCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFS ITQFKHLGRLLMVHGRNSYKRSAALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYP ELYKDLLKGRPLSYKTFLIWVLISIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVF -------------------------------------------------------------- >58787_58787_2_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000371564_ATP9A_chr20_50292747_ENST00000338821_length(amino acids)=1400AA_BP=619 MRAMNAPERQPQPDGGDAPGHEPGGSPQDELDFSILFDYEYLNPNEEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFG EPDRVGPQKFLSAAKPAGASGLSPRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSAS FISDTFSPYTSPCVSPNNGGPDDLCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGA SPQRSRSPSPQPSSHVAPQDHGSPAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQ GERRNSAPESILLVPPTWPKPLVPAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHG YMENKPLGLQIFIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGR KNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTG RELRSVMNTSNPRSKIGLFDLEVNCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSK IPGTVVRSSTIPEQLGRISYLLTDKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVH EAVKAIALCHNVTPVYESNGVTDQAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYE SKRMGIIVRDESTGEITFYMKGADVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIE SLEMEMELLCLTGVEDQLQADVRPTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCAL VISGDSLEVCLKYYEYEFMELACQCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFS ITQFKHLGRLLMVHGRNSYKRSAALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYP ELYKDLLKGRPLSYKTFLIWVLISIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVF -------------------------------------------------------------- >58787_58787_3_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000371564_ATP9A_chr20_50292747_ENST00000402822_length(amino acids)=1400AA_BP=619 MRAMNAPERQPQPDGGDAPGHEPGGSPQDELDFSILFDYEYLNPNEEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFG EPDRVGPQKFLSAAKPAGASGLSPRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSAS FISDTFSPYTSPCVSPNNGGPDDLCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGA SPQRSRSPSPQPSSHVAPQDHGSPAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQ GERRNSAPESILLVPPTWPKPLVPAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHG YMENKPLGLQIFIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGR KNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTG RELRSVMNTSNPRSKIGLFDLEVNCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSK IPGTVVRSSTIPEQLGRISYLLTDKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVH EAVKAIALCHNVTPVYESNGVTDQAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYE SKRMGIIVRDESTGEITFYMKGADVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIE SLEMEMELLCLTGVEDQLQADVRPTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCAL VISGDSLEVCLKYYEYEFMELACQCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFS ITQFKHLGRLLMVHGRNSYKRSAALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYP ELYKDLLKGRPLSYKTFLIWVLISIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVF -------------------------------------------------------------- >58787_58787_4_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000396009_ATP9A_chr20_50292747_ENST00000311637_length(amino acids)=1400AA_BP=619 MRAMNAPERQPQPDGGDAPGHEPGGSPQDELDFSILFDYEYLNPNEEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFG EPDRVGPQKFLSAAKPAGASGLSPRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSAS FISDTFSPYTSPCVSPNNGGPDDLCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGA SPQRSRSPSPQPSSHVAPQDHGSPAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQ GERRNSAPESILLVPPTWPKPLVPAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHG YMENKPLGLQIFIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGR KNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTG RELRSVMNTSNPRSKIGLFDLEVNCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSK IPGTVVRSSTIPEQLGRISYLLTDKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVH EAVKAIALCHNVTPVYESNGVTDQAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYE SKRMGIIVRDESTGEITFYMKGADVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIE SLEMEMELLCLTGVEDQLQADVRPTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCAL VISGDSLEVCLKYYEYEFMELACQCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFS ITQFKHLGRLLMVHGRNSYKRSAALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYP ELYKDLLKGRPLSYKTFLIWVLISIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVF -------------------------------------------------------------- >58787_58787_5_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000396009_ATP9A_chr20_50292747_ENST00000338821_length(amino acids)=1400AA_BP=619 MRAMNAPERQPQPDGGDAPGHEPGGSPQDELDFSILFDYEYLNPNEEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFG EPDRVGPQKFLSAAKPAGASGLSPRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSAS FISDTFSPYTSPCVSPNNGGPDDLCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGA SPQRSRSPSPQPSSHVAPQDHGSPAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQ GERRNSAPESILLVPPTWPKPLVPAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHG YMENKPLGLQIFIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGR KNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTG RELRSVMNTSNPRSKIGLFDLEVNCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSK IPGTVVRSSTIPEQLGRISYLLTDKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVH EAVKAIALCHNVTPVYESNGVTDQAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYE SKRMGIIVRDESTGEITFYMKGADVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIE SLEMEMELLCLTGVEDQLQADVRPTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCAL VISGDSLEVCLKYYEYEFMELACQCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFS ITQFKHLGRLLMVHGRNSYKRSAALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYP ELYKDLLKGRPLSYKTFLIWVLISIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVF -------------------------------------------------------------- >58787_58787_6_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000396009_ATP9A_chr20_50292747_ENST00000402822_length(amino acids)=1400AA_BP=619 MRAMNAPERQPQPDGGDAPGHEPGGSPQDELDFSILFDYEYLNPNEEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFG EPDRVGPQKFLSAAKPAGASGLSPRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSAS FISDTFSPYTSPCVSPNNGGPDDLCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGA SPQRSRSPSPQPSSHVAPQDHGSPAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQ GERRNSAPESILLVPPTWPKPLVPAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHG YMENKPLGLQIFIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGR KNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTG RELRSVMNTSNPRSKIGLFDLEVNCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSK IPGTVVRSSTIPEQLGRISYLLTDKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVH EAVKAIALCHNVTPVYESNGVTDQAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYE SKRMGIIVRDESTGEITFYMKGADVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIE SLEMEMELLCLTGVEDQLQADVRPTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCAL VISGDSLEVCLKYYEYEFMELACQCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFS ITQFKHLGRLLMVHGRNSYKRSAALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYP ELYKDLLKGRPLSYKTFLIWVLISIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVF -------------------------------------------------------------- >58787_58787_7_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000414705_ATP9A_chr20_50292747_ENST00000311637_length(amino acids)=1377AA_BP=596 MQREAAFRLGHCHPLRIMGSVDQEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFGEPDRVGPQKFLSAAKPAGASGLS PRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSASFISDTFSPYTSPCVSPNNGGPDD LCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGASPQRSRSPSPQPSSHVAPQDHGS PAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQGERRNSAPESILLVPPTWPKPLV PAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQIFIGTADERILKP HAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSL QTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTGRELRSVMNTSNPRSKIGLFDLEV NCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSKIPGTVVRSSTIPEQLGRISYLLT DKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVHEAVKAIALCHNVTPVYESNGVTD QAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYESKRMGIIVRDESTGEITFYMKGA DVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIESLEMEMELLCLTGVEDQLQADVR PTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCALVISGDSLEVCLKYYEYEFMELAC QCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFSITQFKHLGRLLMVHGRNSYKRSA ALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYPELYKDLLKGRPLSYKTFLIWVLI SIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVFLHEFIDVYFIATLSFLWKVSVIT -------------------------------------------------------------- >58787_58787_8_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000414705_ATP9A_chr20_50292747_ENST00000338821_length(amino acids)=1377AA_BP=596 MQREAAFRLGHCHPLRIMGSVDQEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFGEPDRVGPQKFLSAAKPAGASGLS PRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSASFISDTFSPYTSPCVSPNNGGPDD LCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGASPQRSRSPSPQPSSHVAPQDHGS PAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQGERRNSAPESILLVPPTWPKPLV PAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQIFIGTADERILKP HAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSL QTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTGRELRSVMNTSNPRSKIGLFDLEV NCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSKIPGTVVRSSTIPEQLGRISYLLT DKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVHEAVKAIALCHNVTPVYESNGVTD QAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYESKRMGIIVRDESTGEITFYMKGA DVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIESLEMEMELLCLTGVEDQLQADVR PTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCALVISGDSLEVCLKYYEYEFMELAC QCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFSITQFKHLGRLLMVHGRNSYKRSA ALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYPELYKDLLKGRPLSYKTFLIWVLI SIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVFLHEFIDVYFIATLSFLWKVSVIT -------------------------------------------------------------- >58787_58787_9_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000414705_ATP9A_chr20_50292747_ENST00000402822_length(amino acids)=1377AA_BP=596 MQREAAFRLGHCHPLRIMGSVDQEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFGEPDRVGPQKFLSAAKPAGASGLS PRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSASFISDTFSPYTSPCVSPNNGGPDD LCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGASPQRSRSPSPQPSSHVAPQDHGS PAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQGERRNSAPESILLVPPTWPKPLV PAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQIFIGTADERILKP HAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSL QTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTGRELRSVMNTSNPRSKIGLFDLEV NCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSKIPGTVVRSSTIPEQLGRISYLLT DKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVHEAVKAIALCHNVTPVYESNGVTD QAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYESKRMGIIVRDESTGEITFYMKGA DVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIESLEMEMELLCLTGVEDQLQADVR PTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCALVISGDSLEVCLKYYEYEFMELAC QCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFSITQFKHLGRLLMVHGRNSYKRSA ALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYPELYKDLLKGRPLSYKTFLIWVLI SIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVFLHEFIDVYFIATLSFLWKVSVIT -------------------------------------------------------------- >58787_58787_10_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000609943_ATP9A_chr20_50292747_ENST00000311637_length(amino acids)=1377AA_BP=596 MQREAAFRLGHCHPLRIMGSVDQEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFGEPDRVGPQKFLSAAKPAGASGLS PRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSASFISDTFSPYTSPCVSPNNGGPDD LCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGASPQRSRSPSPQPSSHVAPQDHGS PAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQGERRNSAPESILLVPPTWPKPLV PAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQIFIGTADERILKP HAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSL QTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTGRELRSVMNTSNPRSKIGLFDLEV NCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSKIPGTVVRSSTIPEQLGRISYLLT DKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVHEAVKAIALCHNVTPVYESNGVTD QAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYESKRMGIIVRDESTGEITFYMKGA DVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIESLEMEMELLCLTGVEDQLQADVR PTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCALVISGDSLEVCLKYYEYEFMELAC QCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFSITQFKHLGRLLMVHGRNSYKRSA ALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYPELYKDLLKGRPLSYKTFLIWVLI SIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVFLHEFIDVYFIATLSFLWKVSVIT -------------------------------------------------------------- >58787_58787_11_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000609943_ATP9A_chr20_50292747_ENST00000338821_length(amino acids)=1377AA_BP=596 MQREAAFRLGHCHPLRIMGSVDQEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFGEPDRVGPQKFLSAAKPAGASGLS PRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSASFISDTFSPYTSPCVSPNNGGPDD LCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGASPQRSRSPSPQPSSHVAPQDHGS PAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQGERRNSAPESILLVPPTWPKPLV PAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQIFIGTADERILKP HAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSL QTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTGRELRSVMNTSNPRSKIGLFDLEV NCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSKIPGTVVRSSTIPEQLGRISYLLT DKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVHEAVKAIALCHNVTPVYESNGVTD QAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYESKRMGIIVRDESTGEITFYMKGA DVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIESLEMEMELLCLTGVEDQLQADVR PTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCALVISGDSLEVCLKYYEYEFMELAC QCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFSITQFKHLGRLLMVHGRNSYKRSA ALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYPELYKDLLKGRPLSYKTFLIWVLI SIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVFLHEFIDVYFIATLSFLWKVSVIT -------------------------------------------------------------- >58787_58787_12_NFATC2-ATP9A_NFATC2_chr20_50071085_ENST00000609943_ATP9A_chr20_50292747_ENST00000402822_length(amino acids)=1377AA_BP=596 MQREAAFRLGHCHPLRIMGSVDQEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFGEPDRVGPQKFLSAAKPAGASGLS PRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSASFISDTFSPYTSPCVSPNNGGPDD LCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGASPQRSRSPSPQPSSHVAPQDHGS PAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQGERRNSAPESILLVPPTWPKPLV PAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQIFIGTADERILKP HAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSL QTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTGTVVGVVLYTGRELRSVMNTSNPRSKIGLFDLEV NCLTKILFGALVVVSLVMVALQHFAGRWYLQIIRFLLLFSNIIPISLRVNLDMGKIVYSWVIRRDSKIPGTVVRSSTIPEQLGRISYLLT DKTGTLTQNEMIFKRLHLGTVAYGLDSMDEVQSHIFSIYTQQSQDPPAQKGPTLTTKVRRTMSSRVHEAVKAIALCHNVTPVYESNGVTD QAEAEKQYEDSCRVYQASSPDEVALVQWTESVGLTLVGRDQSSMQLRTPGDQILNFTILQIFPFTYESKRMGIIVRDESTGEITFYMKGA DVVMAGIVQYNDWLEEECGNMAREGLRVLVVAKKSLAEEQYQDFEARYVQAKLSVHDRSLKVATVIESLEMEMELLCLTGVEDQLQADVR PTLETLRNAGIKVWMLTGDKLETATCTAKNAHLVTRNQDIHVFRLVTNRGEAHLELNAFRRKHDCALVISGDSLEVCLKYYEYEFMELAC QCPAVVCCRCAPTQKAQIVRLLQERTGKLTCAVGDGGNDVSMIQESDCGVGVEGKEGKQASLAADFSITQFKHLGRLLMVHGRNSYKRSA ALSQFVIHRSLCISTMQAVFSSVFYFASVPLYQGFLIIGYSTIYTMFPVFSLVLDKDVKSEVAMLYPELYKDLLKGRPLSYKTFLIWVLI SIYQGSTIMYGALLLFESEFVHIVAISFTSLILTELLMVALTIQTWHWLMTVAELLSLACYIASLVFLHEFIDVYFIATLSFLWKVSVIT -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr20:50344281/chr20:50078782) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
NFATC2 | ATP9A |
FUNCTION: In T-helper 2 (Th2) cells, regulates the magnitude of NFAT-driven transcription of a specific subset of cytokine genes, including IL3, IL4, IL5 and IL13, but not IL2. Recruits PRMT1 to the IL4 promoter; this leads to enhancement of histone H4 'Arg-3'-methylation and facilitates subsequent histone acetylation at the IL4 locus, thus promotes robust cytokine expression (By similarity). Down-regulates formation of poly-SUMO chains by UBE2I/UBC9 (By similarity). {ECO:0000250}. | FUNCTION: Plays a role in regulating membrane trafficking of cargo proteins, namely endosome to plasma membrane recycling and endosome to trans-Golgi network retrograde transport (PubMed:27733620, PubMed:30213940). In complex with MON2 and DOP1B, regulates SNX3 retromer-mediated endosomal sorting of WLS, a transporter of Wnt morphogens in developing tissues. Participates in the formation of endosomal carriers that direct WLS trafficking back to Golgi, away from lysosomal degradation (PubMed:30213940). Appears to be implicated in intercellular communication by negatively regulating the release of exosomes (PubMed:30947313). The flippase activity towards membrane lipids and its role in membrane asymmetry remains to be proved (PubMed:30947313). {ECO:0000269|PubMed:27733620, ECO:0000269|PubMed:30213940, ECO:0000269|PubMed:30947313}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 421_428 | 616.3333333333334 | 1989.6666666666667 | DNA binding | . |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 421_428 | 616.3333333333334 | 926.0 | DNA binding | . |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 421_428 | 596.3333333333334 | 639.3333333333334 | DNA binding | . |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 392_574 | 616.3333333333334 | 1989.6666666666667 | Domain | RHD |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 392_574 | 616.3333333333334 | 926.0 | Domain | RHD |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 392_574 | 596.3333333333334 | 639.3333333333334 | Domain | RHD |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 251_253 | 616.3333333333334 | 1989.6666666666667 | Motif | Note=Nuclear localization signal |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 26_34 | 616.3333333333334 | 1989.6666666666667 | Motif | Note=9aaTAD |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 251_253 | 616.3333333333334 | 926.0 | Motif | Note=Nuclear localization signal |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 26_34 | 616.3333333333334 | 926.0 | Motif | Note=9aaTAD |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 251_253 | 596.3333333333334 | 639.3333333333334 | Motif | Note=Nuclear localization signal |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 26_34 | 596.3333333333334 | 639.3333333333334 | Motif | Note=9aaTAD |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 111_116 | 616.3333333333334 | 1989.6666666666667 | Region | Calcineurin-binding |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 119_199 | 616.3333333333334 | 1989.6666666666667 | Region | Note=Trans-activation domain A (TAD-A) |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 161_175 | 616.3333333333334 | 1989.6666666666667 | Region | Required for cytoplasmic retention of the phosphorylated form |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 184_286 | 616.3333333333334 | 1989.6666666666667 | Region | Note=3 X approximate SP repeats |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 111_116 | 616.3333333333334 | 926.0 | Region | Calcineurin-binding |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 119_199 | 616.3333333333334 | 926.0 | Region | Note=Trans-activation domain A (TAD-A) |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 161_175 | 616.3333333333334 | 926.0 | Region | Required for cytoplasmic retention of the phosphorylated form |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 184_286 | 616.3333333333334 | 926.0 | Region | Note=3 X approximate SP repeats |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 111_116 | 596.3333333333334 | 639.3333333333334 | Region | Calcineurin-binding |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 119_199 | 596.3333333333334 | 639.3333333333334 | Region | Note=Trans-activation domain A (TAD-A) |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 161_175 | 596.3333333333334 | 639.3333333333334 | Region | Required for cytoplasmic retention of the phosphorylated form |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 184_286 | 596.3333333333334 | 639.3333333333334 | Region | Note=3 X approximate SP repeats |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 184_200 | 616.3333333333334 | 1989.6666666666667 | Repeat | Note=1 |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 213_229 | 616.3333333333334 | 1989.6666666666667 | Repeat | Note=2 |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 272_286 | 616.3333333333334 | 1989.6666666666667 | Repeat | Note=3%3B approximate |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 184_200 | 616.3333333333334 | 926.0 | Repeat | Note=1 |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 213_229 | 616.3333333333334 | 926.0 | Repeat | Note=2 |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 272_286 | 616.3333333333334 | 926.0 | Repeat | Note=3%3B approximate |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 184_200 | 596.3333333333334 | 639.3333333333334 | Repeat | Note=1 |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 213_229 | 596.3333333333334 | 639.3333333333334 | Repeat | Note=2 |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 272_286 | 596.3333333333334 | 639.3333333333334 | Repeat | Note=3%3B approximate |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 1000_1006 | 266.3333333333333 | 1048.0 | Topological domain | Extracellular | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 1031_1047 | 266.3333333333333 | 1048.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 326_332 | 266.3333333333333 | 1048.0 | Topological domain | Extracellular | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 355_841 | 266.3333333333333 | 1048.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 863_874 | 266.3333333333333 | 1048.0 | Topological domain | Extracellular | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 894_923 | 266.3333333333333 | 1048.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 943_949 | 266.3333333333333 | 1048.0 | Topological domain | Extracellular | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 973_978 | 266.3333333333333 | 1048.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 1000_1006 | 145.33333333333334 | 927.0 | Topological domain | Extracellular | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 1031_1047 | 145.33333333333334 | 927.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 326_332 | 145.33333333333334 | 927.0 | Topological domain | Extracellular | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 355_841 | 145.33333333333334 | 927.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 863_874 | 145.33333333333334 | 927.0 | Topological domain | Extracellular | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 894_923 | 145.33333333333334 | 927.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 943_949 | 145.33333333333334 | 927.0 | Topological domain | Extracellular | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 973_978 | 145.33333333333334 | 927.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 1007_1030 | 266.3333333333333 | 1048.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 304_325 | 266.3333333333333 | 1048.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 333_354 | 266.3333333333333 | 1048.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 842_862 | 266.3333333333333 | 1048.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 875_893 | 266.3333333333333 | 1048.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 924_942 | 266.3333333333333 | 1048.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 950_972 | 266.3333333333333 | 1048.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 979_999 | 266.3333333333333 | 1048.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 1007_1030 | 145.33333333333334 | 927.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 304_325 | 145.33333333333334 | 927.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 333_354 | 145.33333333333334 | 927.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 842_862 | 145.33333333333334 | 927.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 875_893 | 145.33333333333334 | 927.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 924_942 | 145.33333333333334 | 927.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 950_972 | 145.33333333333334 | 927.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 979_999 | 145.33333333333334 | 927.0 | Transmembrane | Helical |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 664_666 | 616.3333333333334 | 1989.6666666666667 | Motif | Note=Nuclear localization signal |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000371564 | - | 6 | 11 | 904_913 | 616.3333333333334 | 1989.6666666666667 | Motif | Note=Nuclear export signal |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 664_666 | 616.3333333333334 | 926.0 | Motif | Note=Nuclear localization signal |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000396009 | - | 6 | 10 | 904_913 | 616.3333333333334 | 926.0 | Motif | Note=Nuclear export signal |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 664_666 | 596.3333333333334 | 639.3333333333334 | Motif | Note=Nuclear localization signal |
Hgene | NFATC2 | chr20:50071085 | chr20:50292747 | ENST00000414705 | - | 6 | 11 | 904_913 | 596.3333333333334 | 639.3333333333334 | Motif | Note=Nuclear export signal |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 120_303 | 266.3333333333333 | 1048.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 2_69 | 266.3333333333333 | 1048.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 92_96 | 266.3333333333333 | 1048.0 | Topological domain | Extracellular | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 120_303 | 145.33333333333334 | 927.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 2_69 | 145.33333333333334 | 927.0 | Topological domain | Cytoplasmic | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 92_96 | 145.33333333333334 | 927.0 | Topological domain | Extracellular | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 70_91 | 266.3333333333333 | 1048.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000338821 | 8 | 28 | 97_119 | 266.3333333333333 | 1048.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 70_91 | 145.33333333333334 | 927.0 | Transmembrane | Helical | |
Tgene | ATP9A | chr20:50071085 | chr20:50292747 | ENST00000402822 | 3 | 23 | 97_119 | 145.33333333333334 | 927.0 | Transmembrane | Helical |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
NFATC2 | NFATC2, EP300, CREBBP, MED31, VIM, PRKCZ, PIN1, MEF2D, IRF4, FOXP3, MAPK9, MAPK8, SUV39H1, TUBA1A, KPNB1, TAF9, HNRNPA1, TFAP4, IRF2BP2, JUN, LRRK2, IQGAP1, CSE1L, TNPO1, PPP2R1A, USP22, GNB2, HCVgp1, CREB1, IKZF1, RPTOR, FOS, CHEK1, SCAI, IKZF2, GSK3B, RUNX1, SATB1, WDR48, NFATC1, ZNF384, ATF7, ZNF131, MAFK, XRCC5, PRKDC, CSNK1D, JUNB, NFYC, PLK1, LIG3, XRCC1, HSPA1A, HLTF, BTAF1, YWHAB, CHAF1B, LEF1, IRF2BP1, JUND, TFAM, MAFG, SSBP1, RANBP9, CHAMP1, RPA1, WDR26, ZNF148, FOXK1, ZNF217, DEK, RPA3, POLG, CACYBP, RPA2, NFYB, PARP1, ETV6, XRCC6, KIF4A, RFC4, RFC3, EGR1, CAD, RFC5, CTBP1, RFC2, BCL11B, YWHAG, KIF2C, RNGTT, PRDM15, ALDH18A1, MTHFD2, YWHAE, MRPL39, TUFM, IFI16, TP53BP1, ERAL1, SSRP1, TRRAP, YWHAQ, HIRA, ERCC3, UBE2S, SUPT6H, ARID1A, HSPA9, POGZ, UHRF1, SUCLA2, HSPA5, DPF2, YWHAZ, GATAD2A, LRRC47, ZMYM2, DNAJA1, IDH3A, SDHA, CBX5, CABIN1, VAPA, CBX3, MRE11A, SMARCA5, EEF2, RB1, MCRS1, EMD, GTF2H2C, GTF2H2, GTF2H2C_2, SUPT5H, RCOR1, VAPB, MRPL17, UQCRC2, TCF12, BEND3, SMARCA4, KDM1A, SMARCD2, AIFM1, MCM2, H2AFY, HSPA8, POLDIP2, RAD50, SMARCC1, POLR1C, TIMM50, MTA2, HADHA, TLK2, TLK1, RBBP4, GATAD2B, RANBP2, CEBPE, ADNP, SMARCE1, CNP, CBX1, SMARCC2, ZNF24, CHD4, SMARCD1, MBD3, NUDC, ACTL6A, MTA1, IDH3B, CSTF1, RPL23, PPP1CA, HSPH1, PMPCB, GTF3C5, TCP1, GTF3C4, DCAF7, HDAC1, NKX2-1, KIAA1429, ESR1, EGFR, CIC, SOCS3, |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
NFATC2 | |
ATP9A |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to NFATC2-ATP9A |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to NFATC2-ATP9A |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | NFATC2 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Hgene | NFATC2 | C0020542 | Pulmonary Hypertension | 1 | CTD_human |
Hgene | NFATC2 | C0027765 | nervous system disorder | 1 | CTD_human |